INITIAL FILING

Company

RIGEL PHARMACEUTICALS INC

Filed

October 26, 2005

Accession Number

0000899140-05-000961

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →